Immunotherapy in organ-transplanted cancer patients: efficacy and risk of organ rejection

Ann Oncol. 2019 Jul 1;30(7):1173-1177. doi: 10.1093/annonc/mdz129.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Agents, Immunological / therapeutic use*
  • Female
  • Graft Rejection / diagnosis*
  • Graft Rejection / etiology
  • Graft Rejection / immunology
  • Humans
  • Immune Tolerance / drug effects
  • Immunotherapy / methods*
  • Male
  • Middle Aged
  • Molecular Targeted Therapy
  • Neoplasms / drug therapy*
  • Neoplasms / immunology
  • Neoplasms / pathology
  • Organ Transplantation*
  • Prognosis
  • Risk Factors
  • Young Adult

Substances

  • Antineoplastic Agents, Immunological